Dan Guyer
Psychiatry · Grosse Pointe Farms, MINPI 1013937184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 308 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,788 and has fallen 82.3% since, to $494 in 2021. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 308 payments — averaging $14.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$603
- Avanir Pharmaceuticals, Inc.$585
- Lundbeck LLC$469
- AbbVie$381
- Johnson & Johnson$369
- Sunovion Pharmaceuticals Inc.$332
- plus $2K from 20 others
What the payments were for
- Travel & lodging$150%
- Food & beverage$4,50299%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 32 | $603 |
| Avanir Pharmaceuticals, Inc. | 40 | $585 |
| Lundbeck LLC | 38 | $469 |
| AbbVie(2 entities) | 29 | $381 |
| Johnson & Johnson | 14 | $369 |
| Sunovion Pharmaceuticals Inc. | 26 | $332 |
| Otsuka America Pharmaceutical, Inc. | 30 | $273 |
| Teva Pharmaceuticals USA, Inc. | 12 | $206 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $199 |
| Vanda Pharmaceuticals Inc. | 15 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $173 |
| Shire North American Group Inc | 11 | $150 |
| Ironshore Pharmaceuticals Inc. | 5 | $142 |
| Validus Pharmaceuticals LLC | 8 | $121 |
| Neos Therapeutics, LP | 4 | $64 |
| Adlon Therapeutics L.p. | 4 | $55 |
| Indivior Inc. | 3 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $36 |
| Eisai Inc. | 2 | $35 |
| Tris Pharma Inc | 2 | $33 |
| Alfasigma USA, Inc. | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$127
- INGREZZA$123
- INVEGA SUSTENNA$101
How this compares
$4,547 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in Grosse Pointe Farms
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
- Theodore RuzaWest Bloomfield$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.